Evidence map›Paper›PMID 34267305›Full record

ArticleCommunications biology2021

Function-adaptive clustered nanoparticles reverse Streptococcus mutans dental biofilm and maintain microbiota balance.

Fatemeh Ostadhossein, Parikshit Moitra, Esra Altun, Debapriya Dutta, Dinabandhu Sar, Indu Tripathi, Shih-Hsuan Hsiao, Valeriya Kravchuk, Shuming Nie, Dipanjan Pan

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Understanding bacterial biofilms: From definition to treatment strategies.Frontiers in cellular and infection microbiology · 2023
    Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Recent progress in carbon dots for anti-pathogen applications in oral cavity.Frontiers in cellular and infection microbiology · 2023
    Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Fatemeh OstadhosseinDepartments of Bioengineering, Beckman Institute, University of Illinois at Urbana-Champaign, Mills Breast Cancer Institute, and Carle Foundation Hospital, Urbana, IL, USA.ORCID http://orcid.org/0000-0003-4213-7948
Parikshit MoitraDepartment of Pediatrics, Center for Blood Oxygen Transport and Hemostasis, Health Sciences Facility III, University of Maryland Baltimore School of Medicine, Baltimore, MD, USA.
Esra Altun *Departments of Bioengineering, Beckman Institute, University of Illinois at Urbana-Champaign, Mills Breast Cancer Institute, and Carle Foundation Hospital, Urbana, IL, USA.
Debapriya Dutta *Departments of Bioengineering, Beckman Institute, University of Illinois at Urbana-Champaign, Mills Breast Cancer Institute, and Carle Foundation Hospital, Urbana, IL, USA.
Dinabandhu Sar *Departments of Bioengineering, Beckman Institute, University of Illinois at Urbana-Champaign, Mills Breast Cancer Institute, and Carle Foundation Hospital, Urbana, IL, USA.
Indu Tripathi *Departments of Bioengineering, Beckman Institute, University of Illinois at Urbana-Champaign, Mills Breast Cancer Institute, and Carle Foundation Hospital, Urbana, IL, USA.
Shih-Hsuan HsiaoVeterinary Diagnostic Laboratory, University of Illinois at Urbana-Champaign, Urbana, IL, USA.
Valeriya KravchukDepartments of Bioengineering, Beckman Institute, University of Illinois at Urbana-Champaign, Mills Breast Cancer Institute, and Carle Foundation Hospital, Urbana, IL, USA.
Shuming NieDepartments of Bioengineering, Carle Illinois College of Medicine, Beckman Institute, Department of Chemistry, Department of Materials Science and Engineering, University of Illinois at Urbana-Champaign, Urbana, IL, USA.ORCID http://orcid.org/0000-0002-7328-1144
Dipanjan PanDepartments of Bioengineering, Beckman Institute, University of Illinois at Urbana-Champaign, Mills Breast Cancer Institute, and Carle Foundation Hospital, Urbana, IL, USA. dipanjan@som.umaryland.edu.ORCID http://orcid.org/0000-0003-0175-4704
Carle Foundation Hospital · USUniversity of Illinois Urbana-Champaign · USUniversity of Maryland, Baltimore · US

Funding

A Sensing Platform for Rapid at Home-Test of COVID-19R03EB028026 · NIBIB · UNIVERSITY OF MARYLAND BALTIMORE COUNTY · PI PAN, DIPANJAN · 2019 to 2020
$300k
NIBIB NIH HHS R03 EB028026
6 · The paper itself

Abstract

Dental plaques are biofilms that cause dental caries by demineralization with acidogenic bacteria. These bacteria reside inside a protective sheath which makes any curative treatment challenging. We propose an antibiotic-free strategy to disrupt the biofilm by engineered clustered carbon dot nanoparticles that function in the acidic environment of the biofilms. In vitro and ex vivo studies on the mature biofilms of Streptococcus mutans revealed >90% biofilm inhibition associated with the contact-mediated interaction of nanoparticles with the bacterial membrane, excessive reactive oxygen species generation, and DNA fragmentation. An in vivo examination showed that these nanoparticles could effectively suppress the growth of S. mutans. Importantly, 16S rRNA analysis of the dental microbiota showed that the diversity and richness of bacterial species did not substantially change with nanoparticle treatment. Overall, this study presents a safe and effective approach to decrease the dental biofilm formation without disrupting the ecological balance of the oral cavity.

Indexed as

AnimalsAnti-Bacterial AgentsBiofilmsFemaleHumansMiceMicrobial ViabilityMicrobiotaMicroscopy, Atomic ForceMicroscopy, Electron, ScanningMicroscopy, Electron, TransmissionNanoparticlesNIH 3T3 CellsPolymersRatsRats, Sprague-DawleyAnti-Bacterial AgentsPolymersRNA, Ribosomal, 16S

Identifiers

PMID34267305
PMCPMC8282845
OpenAlexW3182541299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.